Cover Image
市場調查報告書

MediPoint:運動醫學 - 全球市場的分析與預測

MediPoint: Sports Medicine - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 298493
出版日期 內容資訊 英文 243 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:運動醫學 - 全球市場的分析與預測 MediPoint: Sports Medicine - Global Analysis and Market Forecasts
出版日期: 2014年03月27日 內容資訊: 英文 243 Pages
簡介

本報告提供全球運動醫學(包含移植·關節鏡的資本設備)市場相關調查分析,以主要國家(美國,法國,德國,義大利,西班牙,英國,日本,巴西,中國,印度)的整形外科的運動醫學為焦點,提供產業概要,未滿足需求,市場機會,競爭評估,開發中產品,臨床試驗相關驗證,再加上主要企業簡介,市場預測等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 臨床結果

  • 保存療法
  • 藥物療法
  • 軟組織的修復
  • 關節鏡檢查
  • 骨板與螺絲
  • 關節重建

第4章 產業概要

  • 概要
  • 治療趨勢
  • 市場進入
  • 糾紛和解決
  • 合併,收購,夥伴關係,其他交易
  • 經濟影響

第5章 未滿足需求

  • 長期臨床資料
  • 軟骨·半月軟骨修復的產品開發
  • 早期治癒的生技藥品
  • 器具的標準化與改善
  • 特別研究員的進修計劃
  • 高級材料的研究
  • 生物吸收性的技術開發
  • 集中化
  • 成本控制的必要性
  • 縫合基礎螺栓產品的開發

第6章 市場機會分析

第7章 推動市場要素·障礙·替代

  • 推動因素
  • 障礙
  • 替代

第8章 競爭評估

  • 概要
  • 運動醫學的上市產品
    • Arthrex
    • ArthroCare Corporation
    • Biomet
    • ConMed Corporation
    • DePuy Mitek
    • Smith & Nephew
    • Stryker
    • Tornier

第9章 開發平台評估

  • 概要
  • 產品簡介

第10章 值得注意的臨床試驗

第11章 現在/未來的主要企業

  • 企業策略趨勢
  • 企業簡介
    • Arthrex
    • ArthroCare Corporation
    • Biomet
    • ConMed Corporation
    • DePuy Companies
    • Smith & Nephew
    • Stryker
    • Tornier
    • Wright Medical Group
    • Other Key Players in Sports Medicine

第12章 市場預測

  • 企業的市場佔有率
  • 市場部門別
  • 各地區

第13章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME206MAR

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

Highlights

Key Questions Answered

  • The sports medicine market is expected to continue its growth through the forecast period with growth driven by young athletes injuring themselves more and a growing elderly population that wishes to continue their recreational activity. (Q). What are the primary patient segments, indications and different product offerings in sports medicine?
  • Orthopedics has seen rapid development in materials research and new techniques for surgical treatment. And sports medicine is one of the higher growth markets. (Q). What specific technologies will drive the market? (Q). How have the indications changed and are procedural numbers growing proportionately to market size?(Q). What are the future trends and drivers for growth in this market?
  • Joint replacement in orthopedics is growing rapidly in the extremities and less so in large joints.(Q). Is arthroscopic surgery a viable alternative?(Q). Do we see pricing pressure in the sports medicine implants?(Q). Which product segment will have the most innovation?
  • The top players in this market are dominating sports medicine implants and equipment worldwide. (Q). What role do smaller players have in grabbing market share in the different global regions? (Q). Who are the large players in sports medicine in each product segment?

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Orthopedic Sports MedicineSurgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Clinical Outcomes

  • 3.1. Conservative Treatments
    • 3.1.1. Immobilization and Bracing
    • 3.1.2. Physical Therapy
    • 3.1.3. Muscle Stimulation
  • 3.2. Drug Therapy
    • 3.2.1. Nutritional Supplements
    • 3.2.2. Analgesics and NSAIDs
    • 3.2.3. Corticosteroids
    • 3.2.4. Viscosupplementation
  • 3.3. Soft Tissue Repair
  • 3.4. Arthroscopy
  • 3.5. Plates and Screws
  • 3.6. Joint Replacement

4. Industry Overview

  • 4.1. Overview
  • 4.2. Procedure Trends
    • 4.2.1. US
    • 4.2.2. EU
    • 4.2.3. Asia-Pacific Region
    • 4.2.4. South America
  • 4.3. Market Access
    • 4.3.1. US
    • 4.3.2. EU
    • 4.3.3. Asia-Pacific Region
    • 4.3.4. South America
  • 4.4. Disputes and Settlements
    • 4.4.1. Smith & Nephew Granted an Injunction Against Arthrex
    • 4.4.2. KFx Medical and Smith & Nephew Enter Into Licensing Agreement
    • 4.4.3. KFx Medical Wins Patent Infringement Lawsuit Against Arthrex
    • 4.4.4. ArthroCare and Smith & Nephew Settle Legal Disputes
  • 4.5. Mergers, Acquisitions, Partnerships, and Other Deals
    • 4.5.1. Stryker Acquires Pivot Medical
    • 4.5.2. Smith & Nephew Announces Acquisition of ArthroCare
    • 4.5.3. Smith & Nephew Acquires Plato Grup Assets
    • 4.5.4. Smith & Nephew Announces Acquisition of Its Brazil Distribution Business
    • 4.5.5. Kensey Nash Acquires Minority Stake in Orteq Sports Medicine
    • 4.5.6. Tornier Acquires C2M Medical
    • 4.5.7. Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation
    • 4.5.8. Biomet Acquires Cartilix
    • 4.5.9. Biomet Sports Medicine Enters Into Deal With Marc Tec
  • 4.6. Economic Impact
    • 4.6.1. Developed Countries
    • 4.6.2. Emerging Markets

5. Unmet Needs

  • 5.1. Long-Term Clinical Data
    • 5.1.1. Hip Arthroscopic Implants Clinical Data
    • 5.1.2. Rotator Cuff Injury Clinical Data
  • 5.2. Cartilage and Meniscal Repair Product Development
    • 5.2.1. Knee Meniscus Treatment
    • 5.2.2. Hip Cartilage Product Development
  • 5.3. Biologics for Faster Healing
  • 5.4. Standardization and Improvement of Instruments
    • 5.4.1. Hip and Shoulder Instrumentation
    • 5.4.2. Screwdriver Standardization
  • 5.5. Fellowship Training Programs
  • 5.6. Advanced Materials Research
  • 5.7. Bioabsorbable Technology Development
  • 5.8. Centralization
  • 5.9. Need for Cost-Containment
  • 5.10. Suture Anchor Product Development

6. Market Opportunity Analysis

  • 6.1. Adding More Training Programs
  • 6.2. Product Line Extensions
  • 6.3. Lack of Pricing Pressure in Sports Medicine
  • 6.4. Mergers and Acquisitions
  • 6.5. Seasonality of Sports Medicine
  • 6.6. Emerging Markets
  • 6.7. Minimally-Invasive Surgical Preference

7. Market Drivers, Barriers and Substitutes

  • 7.1. Driver: Rising Prevalence
    • 7.1.1. Sports-Related Injuries
    • 7.1.2. Aging
    • 7.1.3. Trauma
  • 7.2. Driver: Hip Arthroscopy
    • 7.2.1. Femoroacetabular Impingement Growth
    • 7.2.2. Hip Arthroscopy Fellowship Training Programs
  • 7.3. Driver: Knee and Shoulder Arthroscopy
  • 7.4. Driver: Revision Surgery
  • 7.5. Driver: Patient Demand and Awareness
  • 7.6. Driver: Orthobiologics Development
    • 7.6.1. Bone Grafts
    • 7.6.2. Platelet-Rich Plasma
  • 7.7. Driver: Rising Competition and Innovation Through Small Players
  • 7.8. Driver: Materials Development
    • 7.8.1. Composite Materials and Biopolymers
    • 7.8.2. Bioabsorbables
    • 7.8.3. Metallic Alloys in Orthopedics
  • 7.9. Barrier: Arthroscopy's Questionable Outcomes
    • 7.9.1. Hip Arthroscopy
    • 7.9.2. Knee Arthroscopy
  • 7.10. Barrier: Steep Learning Curve
  • 7.11. Barrier: Reimbursement
  • 7.12. Barrier: Burden of Rising Regulation
  • 7.13. Barrier: Proving Efficacy
  • 7.14. Barrier: Medical Device Excise Tax
  • 7.15. Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy
  • 7.16. Substitute: Conservative Treatment Options

8. Competitive Assessment

  • 8.1. Overview
  • 8.2. Marketed Products in Sports Medicine
    • 8.2.1. Arthrex
    • 8.2.2. ArthroCare Corporation
    • 8.2.3. Biomet
    • 8.2.4. ConMed Corporation
    • 8.2.5. DePuy Mitek
    • 8.2.6. Smith & Nephew
    • 8.2.7. Stryker
    • 8.2.8. Tornier

9. Pipeline Assessment

  • 9.1. Overview
  • 9.2. Product Profiles
    • 9.2.1. Bioretec Drug-Releasing Screws
    • 9.2.2. Nanova Bioabsorbable Bone Screws
    • 9.2.3. MinInvasive Arthroscopic Suture Passer
    • 9.2.4. SpineSmith Pipeline
    • 9.2.5. DePuy Mitek FMS VUE
    • 9.2.6. Pivot Medical Hip Arthroscopy System
    • 9.2.7. University of Florida Shoulder Labral Anchor Delivery System
    • 9.2.8. University of California at San Diego Cartilage Regeneration Device

10. Clinical Trials to Watch

  • 10.1. Overview
  • 10.2. Can Shoulder Arthroscopy Work (CSAW) Study
  • 10.3. Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • 10.4. Knee Arthroscopy Cohort Southern Denmark
  • 10.5. Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • 10.6. Femoroacetabular Impingement Randomized Controlled Trial
  • 10.7. Multicenter ACL Revision Study (MARS)
  • 10.8. Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • 10.9. Microfracture in the Knee Study
  • 10.10. Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • 10.11. Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • 10.12. Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • 10.13. Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma
  • 10.14. Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews

11. Current and Future Players

  • 11.1. Trends in Corporate Strategy
  • 11.2. Company Profiles
    • 11.2.1. Arthrex
    • 11.2.2. ArthroCare Corporation
    • 11.2.3. Biomet
    • 11.2.4. ConMed Corporation
    • 11.2.5. DePuy Companies
    • 11.2.6. Smith & Nephew
    • 11.2.7. Stryker
    • 11.2.8. Tornier
    • 11.2.9. Wright Medical Group
    • 11.2.10. Other Key Players in Sports Medicine

12. Market Outlook

  • 12.1. Company Market Share
    • 12.1.1. Overview
    • 12.1.2. US
    • 12.1.3. EU Market Share
    • 12.1.4. Asia-Pacific Market Share
    • 12.1.5. South America Market Share
  • 12.2. By Market Segment
    • 12.2.1. Overview
    • 12.2.2. Arthroscopy Implants
    • 12.2.3. Arthroscopic Shavers
    • 12.2.4. Arthroscopes
    • 12.2.5. Arthroscopic Radio Frequency Wands
    • 12.2.6. Arthroscopic Visualization Systems
    • 12.2.7. Arthroscopic Fluid Management Systems
  • 12.3. By Geography
    • 12.3.1. Global Overview
    • 12.3.2. US
    • 12.3.3. EU
    • 12.3.4. Asia-Pacific
    • 12.3.5. South America

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Research Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Physicians and Specialists Included in this Study
    • 13.4.1. Dr. Henry D.E. Atkinson
    • 13.4.2. Dr. Joshua Alpert
    • 13.4.3. Dr. Andrea Ferretti
    • 13.4.4. Dr. Alejandro Gonzalez Della Valle
    • 13.4.5. Dr. Andreas Imhoff
    • 13.4.6. Dr. Marcello Zaia Oliveira
    • 13.4.7. Dr. Vidhya Ravi
    • 13.4.8. Dr. Elvire Servien
    • 13.4.9. Dr. Yotaro Yamakado
  • 13.5. Primary Research
    • 13.5.1. Primary Research - Key Opinion Leader Interviews
    • 13.5.2. Primary Research - Physician and Industry Interviews
    • 13.5.3. Expert Panel Validation
  • 13.6. Forecasting Methodology
  • 13.7. About the Authors
    • 13.7.1. Analysts
    • 13.7.2. Global Head of Healthcare
  • 13.8. About MediPoint
  • 13.9. About GlobalData
  • 13.10. Disclaimer

List of Tables

  • Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine
  • Table 2: Growth Rates for Arthroscopy by Joint in the US, 2013-2020
  • Table 3: EU Growth Rate for Arthroscopy by Joint and Country, 2013-2020
  • Table 4: APAC Growth Rate for Arthroscopy by Joint and Country, 2013-2020
  • Table 5: Brazil Growth Rate for Arthroscopy by Joint, 2013-2020
  • Table 6: Medicare ICD-9 Diagnosis Codes for Common Sports Medicine Injuries, 2013
  • Table 7: Medicare National Adjusted Reimbursement Rates for Common Sports Medicine Injuries for Hospital Outpatient Treatment, 2013
  • Table 8: Medicare DRG Payments to Hospitals for Common Sports Medicine Injuries, 2013
  • Table 9: Primary Differences Between FDA Approval and CE-Marking of Medical Devices
  • Table 10: Direct, Indirect, and Intangible Costs of Orthopedics
  • Table 11: Potential Market for Meniscus Treatment Types
  • Table 12: Metal Implant CharacteristicsThat Can Be Improved
  • Table 13: Arthrex Shoulder Implants
  • Table 14: Arthrex, Shoulder Instrumentation
  • Table 15: Arthrex, Knee Sutures and Suture Anchors
  • Table 16: Arthrex, Knee Graft Fixation Devices and Meniscal Products
  • Table 17: Arthrex, Hip Implants and Instruments
  • Table 18: Arthrex, Arthroscopy Procedure Capital Equipment
  • Table 19: Arthrex, Implants SWOT Analysis
  • Table 20: Arthrex, Instrumentation SWOT Analysis
  • Table 21: Arthrocare, Suture Implants
  • Table 22: ArthroCare, Suture Management Products
  • Table 23: ArthroCare, Cruciate Ligament Graft Fixation Products
  • Table 24: ArthroCare, Capital Equipment and Instruments
  • Table 25: ArthroCare, Implants SWOT Analysis
  • Table 26: Arthrocare, Instruments and Capital Equipment SWOT Analysis
  • Table 27: Biomet, Shoulder Arthroscopy Products
  • Table 28: Biomet, Knee Arthroscopy Products
  • Table 29: Biomet's Other Joints Arthroscopy Products
  • Table 30: Biomet, Capital Equipment Sports Medicine Products
  • Table 31: Biomet Implants SWOT Analysis
  • Table 32: Biomet, Capital Equipment SWOT Analysis
  • Table 33: ConMed, Shoulder Arthroscopy Products
  • Table 34: ConMed, Knee Arthroscopy Products
  • Table 35: ConMed, Small Joint and Hip Arthroscopy Products
  • Table 36: ConMed, Instruments and Capital Equipment
  • Table 37: ConMed, Implants SWOT Analysis
  • Table 38: ConMed, Capital Equipment SWOT Analysis
  • Table 39: DePuy Mitek, Fixation Devices
  • Table 40: DePuy, Mitek Instruments
  • Table 41: DePuy Mitek, Capital Equipment
  • Table 42: DePuy Mitek Implants, SWOT Analysis
  • Table 43: DePuy Mitek, Capital Equipment SWOT Analysis
  • Table 44: Smith & Nephew, Fixation Devices
  • Table 45: Smith & Nephew, Instruments and Capital Equipment
  • Table 46: Smith & Nephew Implants, SWOT Analysis
  • Table 47: Smith & Nephew, Capital Equipment SWOT Analysis
  • Table 48: Stryker, Fixation Devices
  • Table 49: Stryker, Instrumentation
  • Table 50: Stryker, Capital Equipment
  • Table 51: Stryker, Fixation Devices SWOT Analysis
  • Table 52: Stryker, Instrumentation and Capital Equipment SWOT Analysis
  • Table 53: Tornier Sports Medicine Products
  • Table 54: Tornier, Product Family SWOT Analysis
  • Table 55: Can Shoulder Arthroscopy Work (CSAW)
  • Table 56: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • Table 57: Knee Arthroscopy Cohort Southern Denmark
  • Table 58: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • Table 59: Femoroacetabular Impingement Randomized Controlled Trial
  • Table 60: Multicenter ACL Revision Study (MARS)
  • Table 61: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • Table 62: Results at 10 to 14 Years After Microfracture in the Knee
  • Table 63: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • Table 64: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • Table 65: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • Table 66: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears
  • Table 67: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews
  • Table 68: Company Profile - Arthrex
  • Table 69: SWOT Analysis - Arthrex
  • Table 70: Company Profile - ArthroCare Corporation
  • Table 71: SWOT Analysis - ArthroCare Corporation
  • Table 72: Company Profile - Biomet
  • Table 73: SWOT Analysis - Biomet
  • Table 74: Company Profile - ConMed Corporation
  • Table 75: SWOT Analysis - ConMed Corporation
  • Table 76: Company Profile - DePuy Companies
  • Table 77: SWOT Analysis - DePuy Companies
  • Table 78: Company Profile - Smith & Nephew
  • Table 79: SWOT Analysis - Smith & Nephew
  • Table 80: Company Profile - Stryker
  • Table 81: SWOT Analysis - Stryker
  • Table 82: Company Profile - Tornier
  • Table 83: SWOT Analysis - Tornier
  • Table 84: Company Profile - Wright Medical Group
  • Table 85: SWOT Analysis - Wright Medical Group
  • Table 86: Other Sports Medicine Companies in the US Market
  • Table 87: Other Sports Medicine Companies in the EU Market
  • Table 88: Other Sports Medicine Companies in the APAC Market
  • Table 89: Global Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 90: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020
  • Table 91: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020
  • Table 92: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020
  • Table 93: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020
  • Table 94: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020
  • Table 95: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020
  • Table 96: Global Sports Medicine Implant and Capital Equipment Sales ($m) Forecast by Country, 2011-2020
  • Table 97: US Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 98: EU Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 99: France Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 100: Germany Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 101: Italy Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 102: Spain Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 103: UK Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 104: Japan Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 105: China Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 106: India Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 107: Brazil Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 108: Primary Research Interviews Completed in Sports Medicine

List of Figures

  • Figure 1: Global Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 2: US Arthroscopic Procedure Volumes, 2011-2020
  • Figure 3: US Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 4: EU Arthroscopic Procedure Volumes, 2011-2020
  • Figure 5: EU Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 6: APAC Region Arthroscopic Procedure Volumes, 2011-2020
  • Figure 7: Brazil Arthroscopic Procedure Volumes, 2011-2020
  • Figure 8: Sources of Orthopedic Trauma (%) (n=103)
  • Figure 9: US Market Share for Arthroscopy, 2012
  • Figure 10: France Market Share for Arthroscopy, 2012
  • Figure 11: Germany Market Share for Arthroscopy, 2012
  • Figure 12: Italy Market Share for Arthroscopy, 2012
  • Figure 13: Spain Market Share for Arthroscopy, 2012
  • Figure 14: UK Market Share for Arthroscopy, 2012
  • Figure 15: Japan Market Share for Arthroscopy, 2012
  • Figure 16: China Market Share for Arthroscopy, 2012
  • Figure 17: India Market Share for Arthroscopy, 2012
  • Figure 18: Brazil Market Share for Arthroscopy, 2012
  • Figure 19: Global Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 20: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020
  • Figure 21: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020
  • Figure 22: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020
  • Figure 23: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020
  • Figure 24: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020
  • Figure 25: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020
  • Figure 26: Arthroscopy Implants Revenue by Major Market, 2013 and 2020
  • Figure 27: Arthroscopy Capital Equipment Revenue by Major Market, 2013 and 2020
  • Figure 28: US Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 29: EU Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 30: France Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 31: Germany Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 32: Italy Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 33: Spain Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 34: UK Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 35: Japan Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 36: China Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 37: India Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 38: Brazil Sports Medicine Sales Forecast ($m), 2011-2020
Back to Top